Literature DB >> 28218057

Propionibacterium acnes is developing gradual increase in resistance to oral tetracyclines.

Keisuke Nakase1, Hidemasa Nakaminami1, Yuko Takenaka2, Nobukazu Hayashi3, Makoto Kawashima2, Norihisa Noguchi1.   

Abstract

Propionibacterium acnes is an anaerobic bacterium that causes deep infection in organs and prosthetic joints, in addition to acne vulgaris. Many tetracycline-resistant P. acnes strains have been isolated because oral tetracyclines are frequently used as an acne treatment against P. acnes. In this study, we found a novel tetracycline resistance mechanism in P. acnes. Three doxycycline-resistant (MIC: 16 µg ml-1) strains were isolated from 69 strains in acne patients in Japan between 2010 and 2011. Additionally, six insusceptible strains (MIC: 1-2 µg ml-1) that had reduced susceptibility compared to susceptible strains (MIC: ≤0.5 µg ml-1) were identified. All doxycycline-resistant strains had a G1036C mutation in the 16S rRNA gene in addition to an amino acid substitution in the ribosomal S10 protein encoded by rpsJ. By contrast, insusceptible strains had an amino acid substitution in the S10 protein but no mutation in the 16S rRNA. When the mutant with decreased susceptibility to doxycycline was obtained in vitro, only the mutated S10 protein was found (MIC: 4 µg ml-1), not the mutated 16S rRNA gene. This result shows that the S10 protein amino acid substitution contributes to reduced doxycycline susceptibility in P. acnes and suggests that tetracycline resistance is acquired through a 16S rRNA mutation after the S10 protein amino acid substitution causes reduced susceptibility.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28218057     DOI: 10.1099/jmm.0.000392

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  5 in total

1.  Transferable Multidrug-Resistance Plasmid Carrying a Novel Macrolide-Clindamycin Resistance Gene, erm(50), in Cutibacterium acnes.

Authors:  Sae Aoki; Keisuke Nakase; Hidemasa Nakaminami; Takeaki Wajima; Nobukazu Hayashi; Norihisa Noguchi
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

Review 2.  Acne, the Skin Microbiome, and Antibiotic Treatment.

Authors:  Haoxiang Xu; Huiying Li
Journal:  Am J Clin Dermatol       Date:  2019-06       Impact factor: 7.403

Review 3.  Precision antimicrobial therapeutics: the path of least resistance?

Authors:  Caitlin N Spaulding; Roger D Klein; Henry L Schreiber; James W Janetka; Scott J Hultgren
Journal:  NPJ Biofilms Microbiomes       Date:  2018-02-27       Impact factor: 7.290

Review 4.  Potential Role of the Microbiome in Acne: A Comprehensive Review.

Authors:  Young Bok Lee; Eun Jung Byun; Hei Sung Kim
Journal:  J Clin Med       Date:  2019-07-07       Impact factor: 4.241

5.  Silent Native-valve Endocarditis Caused by Propionibacterium acnes.

Authors:  Rintaro Yamamoto; Shigeru Miyagawa; Hideharu Hagiya; Keigo Kimura; Isao Nishi; Norihisa Yamamoto; Hisao Yoshida; Yukihiro Akeda; Kazunori Tomono; Koichi Toda; Yoshiki Sawa
Journal:  Intern Med       Date:  2018-03-30       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.